Filing Flows › Comparisons › VTAK vs USAQ
Flyte Aviation vs QHSLab: VTAK and USAQ compared
Flyte Aviation is the larger company: $1.0M of revenue in its latest quarter (Q2 2026) against $847K for QHSLab (Q2 2026). Flyte Aviation is growing faster (+381% against +40% a year earlier). QHSLab is more profitable, with an operating margin of 5.3% against -388.1%.
Where the money goes: VTAK and USAQ
Flyte Aviation (VTAK) · Q2 2026
Flyte Aviation, Q2 2026: revenue $1.0M (+381% year over year), operating margin -388.1%, net loss $3.3M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.
QHSLab (USAQ) · Q2 2026
QHSLab, Q2 2026: revenue $847K (+40% year over year), operating margin 5.3%, net earnings $38K, operating cash flow −$8K. The chart follows the revenue to costs, profit and cash.
| Flyte Aviation (VTAK) | QHSLab (USAQ) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $1.0M | $847K |
| Revenue growth, Y/Y | +381% | +40% |
| Gross margin | — | 69.6% |
| Operating margin | -388.1% | 5.3% |
| Net earnings | −$3.3M | $38K |
| Net margin | -324.4% | 4.5% |
| Operating cash flow | −$2.9M | −$8K |
Where the revenue comes from
Flyte Aviation
- Service: $749K (74%)
- Product: $270K (26%)
QHSLab
- Integrated Service Program: $491K (58%)
- Allergy Diagnostic Kit Sales: $196K (23%)
- Immunotherapy Treatment Sales: $94K (11%)
- Clinical Study Revenue: $30K (4%)
Questions
Which is bigger, Flyte Aviation or QHSLab?
Flyte Aviation is the larger company: $1.0M of revenue in its latest quarter (Q2 2026) against $847K for QHSLab (Q2 2026).
Is Flyte Aviation or QHSLab growing faster?
Flyte Aviation is growing faster (+381% against +40% a year earlier).
Which is more profitable, Flyte Aviation or QHSLab?
QHSLab is more profitable, with an operating margin of 5.3% against -388.1%.
More: Flyte Aviation earnings · how Flyte Aviation makes money · QHSLab earnings · how QHSLab makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.